Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase

Thrombosis Research

Volumn 98, Issue 4, 2000, Pages 323-332

  Bonnefoy, Arnaud ^a   Legrand, Chantal ^a  

^a INSERM   (France)

Author keywords

Extracellular matrix; Fibronectin; Proteinases; Thrombospondin; von Willebrand factor

Indexed keywords

CATHEPSIN G; ELASTASE; FIBRONECTIN; PLASMIN; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

CATHEPSINS; CELL ADHESION; CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; HUMANS; KINETICS; LEUKOCYTE ELASTASE; PEPTIDE FRAGMENTS; PLASMIN; SERINE ENDOPEPTIDASES; THROMBOSPONDINS; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 0034657657     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00242-X     Document Type: Article

References (39)

1. Marcus A.J. Thrombosis and inflammation as multicellular processes. Significance of cell-cell interactions Semin Hematol. 31:1994;261-269.
2. Kirrchhofer D., Riederer M.A., Baumgartner H.R. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood. 89:1997;1270-1278.
3. Ott I., Neumann F.-J., Gawaz M., Schmitt M., Schömig A. Increases neutrophil-platelet adhesion in patient with unstable angina. Circulation. 94:1996;1239-1246.
4. Palabrica T., Lobb R., Furie B.C., Aronovitz M., Benjamin C., Hsu Y.-M., Sajer S.A., Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:1992;848-851.
5. Plow E.F. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest. 69:1982;564-572.
6. Francis C.W., Marder V.J. Degradation of cross-linked fibrin by human leukocyte proteases. J Lab Clin Med. 107:1986;342-352.
7. Harlan J.M., Schwartz B.R., Reidy M.A., Schwartz S.M., Ochs H.D., Harker L.A. Activated neutrophil disrupt endothelial monolayer integrity by an oxygen radical-independent mechanism. Lab Invest. 52:1985;141-150.
8. Westlin W.F., Gimbrone M.A. Jr. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol. 142:1993;117-128.
9. Thompson E.A., Howard M.A. Proteolytic cleavage of human von Willebrand factor induced by enzyme(s) released from polymorphonuclear cells. Blood. 67:1986;1281-1285.
10. Heck L.W., Blackburn W.D., Irwin M.H., Abrahamson D.R. Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am J Pathol. 136:1990;1267-1274.
11. McDonald J.A., Kelley D.G. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem. 255:1980;8848-8858.
12. Salcedo R., Wasserman K., Patarroyo M. Endogenous fibronectin of blood polymorphonuclear leukocytes. stimulus-induced secretion and proteolysis by cell-surface-bound elastase Exp Cell Res. 233:1997;33-40.
13. Owen C.A., Campbell E.J. Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis. Semin Cell Biol. 6:1995;367-376.
14. Henson P.M., Johnson R.B. Jr. Tissue injury in inflammation. Oxydants, proteinases and cationic proteins. J Clin Invest. 79:1987;669-674.
15. Hayman E.G., Pierschbacher M.D., Ruoslathi E. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol. 100:1985;1948-1954.
16. Murphy-Ullrich J.E., Gurusidapa S., Frazier W.A., Höök M. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J Biol Chem. 268:1993;26784-26789.
17. Vogel T., Guo N.H., Krutzsch H.C., Blake D.A., Hartman J., Mendelovitz S., Panet A., Roberts D.D. Modulation of endothelial cell proliferation, adhesion and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J Cell Biochem. 53:1993;74-84.
18. Norris D.A., Clark R.A.F., Swigart L.M., Huff C., Weston W.L., Howell S.E. Fibronectin fragments are chemotactic for human peripheral blood monocytes. J Immunol. 129:1982;1612-1618.
19. Mansfield P.J., Boxer L.A., Suchard S.J. Thrombospondin stimulates motility of human neutrophils. J Cell Biol. 111:1990;3077-3086.
20. Mansfield P.J., Suchard S.J. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol. 153:1994;4219-4229.
21. Sakariassen K.S., Bolhuis P.A., Sixma J.J. Human Blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature. 279:1979;636-638.
22. Mosher D.F., Schad P., Vann J. Cross-linking of collagen and fibronectin by factor XIIIa. Localization of participating glutamyl residues to a tryptic fragment of fibronectin. J Biol Chem. 255:1980;1181-1188.
23. Bockenstedt P., McDonagh J., Handin R.I. Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. J Clin Invest. 78:1986;551-556.
24. Barry E.L.R., Mosher D.F. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. J Biol Chem. 263:1988;10464-10469.
25. Martinez J., Chalupowicz D.G., Roush R.K., Sheth A., Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry. 33:1994;2538-2545.
26. Dubernard V., Legrand C. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton. J Lab Clin Med. 118:1991;446-457.
27. Lawler J., Derick L.H., Connolly J.E., Chen J.H., Chao F.C. The structure of human platelet thrombospondin. J Biol Chem. 260:1985;3762-3772.
28. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52:1973;2745-2756.
29. De Groot P.G., Reinders J.H., Sixma J.J. Perturbation of human endothelial cells by thombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol. 104:1987;697-704.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 227:1970;680-685.
31. Rao C.N., Gomez D.E., Woodley D.T., Thorgeirsson U.P. Partial characterization of novel serine proteinase inhibitors from human umbilical vein endothelial cells. Arch Biochem Biophys. 319:1995;55-62.
32. Hogg P.J., Owensby D.A., Chesterman C.N. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. J Biol Chem. 268:1993;21811-21818.
33. Hogg P.J., Owensby D.A., Mosher D.F., Misenheimer T.M., Chesterman C.N. Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil elastase. J Biol Chem. 268:1993;7139-7146.
34. Rabhi-Sabile S., Pidard D., Lawler J., Renesto P., Chignard M., Legrand C. Proteolysis of thrombospondin during cathepsin G-induced platelet aggregation. Functional role of the 165-kDa carboxy-terminal fragment. FEBS Letters. 386:1996;82-86.
35. Wachtfogel Y.T., Abrams W., Kucich U., Weinbaum G., Schapira M., Colman R.W. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest. 81:1988;1310-1316.
36. Winters K.J., Santoro S.A., Miletich J.P., Eisenberg P.R. Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. Circulation. 84:1991;1552-1560.
37. Vu T., Hung D., Wheaton V., Coughlin S. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
38. Mirza H., Yatsula V., Bahou W.F. The proteinase-activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest. 97:1996;1705-1714.
39. Hogg P.J., Stenflo J., Mosher D.F. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry. 31:1992;265-269.